Also, it can reduce AGEs and CML levels via the Nrf2 (nuclear factor erythroid-2-related-factor-2) pathway, elevating the GSH/GSSG ratio, heme oxygenase-1, and glyoxalase 1 in the liver. This evidence concerns the gene NFE2L2 and chronic myelogenous leukemia, BCR-ABL1 positive.